tiprankstipranks
Trending News
More News >
ACM Research (ACMR)
NASDAQ:ACMR

ACM Research (ACMR) AI Stock Analysis

Compare
2,586 Followers

Top Page

ACMR

ACM Research

(NASDAQ:ACMR)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 5.2)
,
Neutral 58 (OpenAI - 5.2)
,
Neutral 58 (OpenAI - 5.2)
Rating:58Neutral
Price Target:
$48.00
▲(3.00% Upside)
Action:DowngradedDate:03/03/26
The score is held back mainly by volatile/weak cash flow consistency and recent margin compression despite strong revenue growth and a low-leverage, liquid balance sheet. Technicals are mixed with near-term softness, and valuation is relatively expensive (high P/E), while the earnings call supports the outlook with robust 2026 growth guidance but meaningful execution and competitiveness risks.
Positive Factors
Revenue growth and diversification
Consistent multi-year revenue growth and a 2026 guidance implying ~25% YoY growth indicate expanding end-market demand and successful product adoption. Coupled with rising advanced packaging and plating mix, this durable top-line momentum supports scale, R&D funding and market position over the medium term.
Technical leadership and differentiated products
Demonstrated best-in-class SPM nozzle performance and lower-consumption supercritical CO2 tech reflect meaningful product differentiation and likely IP protection. Superior uptime and lower consumable usage strengthen customer TCO, aiding qualification at fabs and supporting sustainable competitive advantage across nodes and packaging segments.
Strong balance sheet and funding for expansion
A sizable net cash position, boosted by recent Shanghai offerings, provides durable financial flexibility to fund Lingang capacity, U.S. onshore Oregon operations and ~$200M 2026 capex. This liquidity reduces refinancing risk, supports qualification cycles, and enables targeted investments to scale manufacturing and global service footprint.
Negative Factors
Inconsistent cash generation
Chronic negative operating and free cash flow in several years means earnings have not reliably converted to cash. This raises execution risk: growth and capex may require external funding or equity monetization, and working-capital swings or inventory builds can magnify liquidity stress during slower shipment periods.
Gross margin compression and inventory hits
A sharp step-down in gross margin and substantial inventory provisions indicate pricing pressure, adverse mix or one-time write-downs. If margin recovery stalls, the company may face constrained operating leverage and diminished ability to fund R&D and capex internally, increasing reliance on external capital or yield-lowering pricing strategies.
Customer concentration and rising competitive pressure
Heavy revenue concentration among a few customers increases downside if priorities shift. Simultaneously, numerous local entrants in China create structural pricing pressure and margin erosion risk. Sustaining share will demand ongoing R&D, service investment, or concessions that could compress returns over the medium term.

ACM Research (ACMR) vs. SPDR S&P 500 ETF (SPY)

ACM Research Business Overview & Revenue Model

Company DescriptionACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating. The company markets and sells its products under the Ultra C brand name through direct sales force and third-party representatives. ACM Research, Inc. was incorporated in 1998 and is headquartered in Fremont, California.
How the Company Makes MoneyACM Research makes money primarily by selling semiconductor capital equipment for wafer cleaning and wet processing. Its key revenue stream is product revenue from the sale of tools and systems (e.g., single-wafer wet cleaning equipment and related wet process platforms, including plating and other wet-processing applications) delivered to semiconductor manufacturers. The company also generates revenue from services and support associated with its installed base, such as customer support, maintenance, spare parts, upgrades, and other after-sales services. Revenue is generally recognized when equipment is delivered/accepted (depending on contract terms) and when services are performed. Significant factors influencing earnings include customers’ capital expenditure cycles in semiconductor fabrication, technology transitions that drive demand for more advanced cleaning and process steps, competitive positioning in wafer wet processing, and the company’s ability to qualify tools at customer fabs and scale manufacturing and service capabilities. Specific partnership details: null.

ACM Research Key Performance Indicators (KPIs)

Any
Any
Revenue by Product
Revenue by Product
Breaks down revenue by each product line, highlighting which products drive the most sales and indicating areas of potential growth or concern based on market demand and product performance.
Chart InsightsSingle-wafer cleaning remains ACM’s largest revenue engine, but the company is clearly diversifying: ECP/furnace grew fastest and now occupies a meaningful share, while advanced-packaging/services are showing a late-cycle acceleration tied to panel-level tool ramp. That mix shift helps explain record revenue but also the drop in gross margin and operating income (inventory provisions and lower-margin systems). Watch Q4 shipment push-outs, parts shortages, and whether planned R&D/production investments turn this momentum into sustained, higher-margin growth.
Data provided by:The Fly

ACM Research Earnings Call Summary

Earnings Call Date:Feb 26, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 01, 2026
Earnings Call Sentiment Neutral
Balanced. The call highlighted solid top-line growth (15% FY), strengthened liquidity (net cash up to $845M), significant product and technical milestones (SPM nozzle performance, supercritical CO2 demo, first Singapore installation, panel-level horizontal plating), and an ambitious 2026 revenue outlook (midpoint implying ~25% growth). Offsetting these positives were notable margin compression (FY gross margin down from 50.4% to 44.5%), lower shipments (down ~12% YoY), higher inventories and provisions, rising OpEx/R&D that pressures near-term operating leverage, and customer concentration and competitive pricing pressures in China. Management frames margin weakness as temporary and highlights a multi-product ramp in 2026, but execution and timing of new-product shipments will determine whether the positives outweigh the near-term challenges.
Q4-2025 Updates
Positive Updates
Top-line Growth — Q4 and Full Year 2025
Revenue of $244 million in Q4 2025, up ~9% year-over-year (CFO: 9.4%); full-year revenue of $901.3 million, up ~15% YoY (CFO: 15.2%). Full-year 2026 guidance reiterated at $1.08B–$1.175B (midpoint implies ~25% YoY growth).
Strong Balance Sheet and Liquidity
Net cash of $845.5 million at year-end 2025 vs $259.1 million at year-end 2024; cash, cash equivalents and time deposits $1.13 billion vs $441 million. Proceeds from ACM Shanghai offerings: ~$623M (2025 private offering) and ~$111M (Feb 2026 sale).
Market Leadership and Product Revenue Mix
Cleaning business generated $626 million (69% of revenue) in 2025, up ~8% YoY and claimed coverage of ~95% of cleaning applications; electroplating/advanced packaging revenue (excluding ECP) grew ~45% in 2025 to ~$76 million, representing accelerating portfolio diversification.
Technical Breakthroughs and Best-in-Class Performance
SPM nozzle redesign achieved a 50 nm particle count under 20 (management cites best-in-class), eliminating routine chamber DI cleaning and boosting uptime; supercritical CO2 dry tool reduces CO2 consumption by ~40% versus competitors in demos.
New Product Wins and Global Customer Momentum
Delivered multiple single-wafer cleaning tools to a Singapore facility (first tool installation to Singapore); received orders from three global customers for wafer-level and panel-level advanced packaging tools with deliveries scheduled in 2026 and later in 2026 for a North America customer; strong repeat orders for SPM cleaning tools.
Manufacturing and Global Expansion
Lingang production and R&D center now primary production site (two buildings supporting up to $3B annual output); Oregon facility investment accelerated with operations expected H2 2026 to support U.S. customers and onshore production; 2026 capex plan ~ $200M to support growth and facilities.
Product Roadmap Progress — Track, PECVD, Furnace and Panel Plating
High-throughput 300 WPH KrF track tool delivered for evaluation with mass production qualification expected in 2026; first Ultra Lith BK system delivered; horizontal panel-level electroplating tool delivered to large panel customer (company positions horizontal approach as advantage vs vertical plating).
Negative Updates
Gross Margin Compression
Q4 gross margin 41.0% (below long-term target 42%–48%); full-year gross margin 44.5% vs 50.4% in 2024 (significant YoY decline). Q4 gross margin down ~8.8 percentage points YoY per management, attributed to product mix and higher inventory provisions.
Shipment Declines and Timing Pushes
Total shipments for 2025 were $854 million vs $973 million in 2024 (down ~12.2%); Q4 shipments $228 million, down ~13.5% YoY. Management noted some new-product shipments were pushed into 2026, contributing to the decline.
Operating Income and Net Income Declines
Q4 operating income $29.5M vs $52.8M prior year; Q4 operating margin 12.1% vs 23.6% prior year. Full-year operating margin 15.9% vs 25.6%. Net income attributable to ACM Research for 2025 was $110.2M vs $152.2M in 2024; diluted EPS $1.61 vs $2.26.
Higher OpEx and R&D Investment Pressure
Operating expenses increased: Q4 OpEx $70.6M (up ~21%), full-year OpEx $258.4M (up ~34%). R&D rose to 15.1% of sales in 2025 with guidance of 16%–18% for 2026, which management expects will pressure near-term operating leverage.
Inventory Levels and Provisions
Total inventory at year-end $702.6M; management cited higher seasonal inventory provisions that contributed ~4 percentage points of gross margin headwind in Q4 and one-time inventory adjustments that depressed margins.
Competitive Pressure and Customer Concentration
Management highlighted a 'flood of new local entrants' in China leading to pricing pressure on semi-critical products. Top 4 customers represented ~52.2% of 2025 sales, indicating concentration risk if relationships or demand shift.
Near-term Margin Recovery Uncertainty
Management expects 2026 operating margin in mid-teens (similar to 2025) with gross margins at the lower end of the 42%–48% target in H1 and improvement in H2; implies limited near-term margin rebound and timing risk tied to new-product ramps.
Company Guidance
ACM reiterated 2026 revenue guidance of $1.08 billion to $1.175 billion (midpoint implying ~25% YoY growth), noted that 2026 shipment growth should exceed revenue growth, and said it expects gross margins to remain in its long‑term target range of 42%–48% but to be at the lower end in H1 2026 with a lift in H2; management expects 2026 operating margin in the mid‑teens (similar to 2025) and model assumptions include R&D of 16%–18% of sales, sales & marketing of 7%–8%, G&A ~6%, an effective tax rate of 8%–10%, and about $200 million of capex in 2026 (vs. $58M in 2025) to fund Lingang expansion, the mini‑line and Oregon operations (starting H2 2026); they also gave revenue seasonality of roughly 18%–20% of revenue in Q1, ~42%–43% in H1 and ~57%–58% in H2, and reaffirmed the longer‑term $4 billion revenue target.

ACM Research Financial Statement Overview

Summary
Strong historical revenue growth and generally healthy profitability, supported by a conservative balance sheet and sizable net cash. However, cash generation is inconsistent (often negative operating and free cash flow) and recent margin compression increases risk around earnings quality and cash conversion.
Income Statement
78
Positive
Revenue growth has been very strong over the period (notably 2021–2023) and still positive in 2024, showing solid demand momentum. Profitability is healthy with gross margin generally in the mid-to-high 40% range and net margin around ~10–14% historically. The main concern is 2025 showing a sharp margin step-down versus 2024 (lower gross and net margins), suggesting higher costs, mix shift, or pricing pressure even as revenue rises.
Balance Sheet
74
Positive
Leverage looks conservative overall, with debt-to-equity generally low and still manageable in 2024–2025, providing financial flexibility. Equity and total assets have grown meaningfully over time, consistent with scaling operations. The trade-off is returns on equity have moderated from stronger levels in earlier years, and 2025 profitability softening reduces the ability to compound equity at prior rates.
Cash Flow
38
Negative
Cash generation is the weak spot: operating cash flow is negative in most years shown (2020–2023 and again 2025), and free cash flow is also negative in most years, implying earnings quality and/or working-capital and investment demands are pressuring cash. 2024 was a clear positive outlier with strong operating and free cash flow, but the relapse to negative cash flow in 2025 raises volatility and execution risk around converting profits into cash.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue901.31M782.12M557.72M388.83M259.75M
Gross Profit400.07M391.55M276.21M183.62M114.86M
EBITDA158.47M180.42M126.99M74.38M41.05M
Net Income94.08M103.63M77.35M39.26M37.76M
Balance Sheet
Total Assets2.87B1.86B1.49B1.24B1.05B
Cash, Cash Equivalents and Short-Term Investments1.17B444.10M283.93M338.65M592.05M
Total Debt302.98M188.78M99.10M79.50M39.14M
Total Liabilities941.68M759.82M564.75M423.33M240.51M
Stockholders Equity1.46B904.63M767.39M674.86M676.20M
Cash Flow
Free Cash Flow-66.61M69.99M-139.66M-154.71M-49.80M
Operating Cash Flow-10.32M152.45M-75.32M-62.19M-40.09M
Investing Cash Flow-390.33M-11.96M-6.75M-265.67M-11.28M
Financing Cash Flow742.49M92.48M18.53M45.87M538.77M

ACM Research Technical Analysis

Technical Analysis Sentiment
Negative
Last Price46.60
Price Trends
50DMA
55.27
Negative
100DMA
45.97
Positive
200DMA
38.19
Positive
Market Momentum
MACD
-3.22
Positive
RSI
38.58
Neutral
STOCH
48.82
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ACMR, the sentiment is Negative. The current price of 46.6 is below the 20-day moving average (MA) of 53.74, below the 50-day MA of 55.27, and above the 200-day MA of 38.19, indicating a neutral trend. The MACD of -3.22 indicates Positive momentum. The RSI at 38.58 is Neutral, neither overbought nor oversold. The STOCH value of 48.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ACMR.

ACM Research Risk Analysis

ACM Research disclosed 61 risk factors in its most recent earnings report. ACM Research reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

ACM Research Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$2.63B21.1011.72%-20.69%-37.67%
73
Outperform
$7.49B82.615.43%2.29%-69.81%
62
Neutral
$1.87B47.894.13%-3.90%-41.66%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
61
Neutral
$3.44B37.65-7.72%1.77%-7.38%99.38%
58
Neutral
$3.06B26.917.79%20.77%26.08%
57
Neutral
$2.70B-6.51-24.06%6.65%-4652.36%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ACMR
ACM Research
46.60
17.38
59.48%
ACLS
Axcelis Technologies
85.74
28.36
49.42%
FORM
Formfactor
96.18
63.55
194.76%
KLIC
Kulicke & Soffa
65.73
30.00
83.97%
UCTT
Ultra Clean Holdings
59.36
34.17
135.65%
VECO
Veeco
31.00
9.16
41.94%

ACM Research Corporate Events

Business Operations and Strategy
ACM Research completes partial share sale in Shanghai unit
Neutral
Feb 6, 2026

On January 30, 2026, ACM Research (Shanghai), Inc. notified the Shanghai Stock Exchange that ACM Research, Inc. intended to sell 4,801,648 ACM Shanghai shares via an inquiry-based transfer, and on February 2, 2026, it set a preliminary transfer price of RMB 160 per share (about $23.05). On February 6, 2026, ACM Shanghai announced that the full 4,801,648 shares had been sold at RMB 160 per share, reducing ACM Research, Inc.’s aggregate ownership in ACM Shanghai—together with its concert parties—from 74.84% to 73.72%, a change described as a shareholding reduction and passive dilution that does not alter ACM Shanghai’s controlling shareholder or actual controller and therefore is not expected to affect control of the company.

The most recent analyst rating on (ACMR) stock is a Buy with a $68.00 price target. To see the full list of analyst forecasts on ACM Research stock, see the ACMR Stock Forecast page.

Business Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance
ACM Research Addresses Outlook, Expands Overseas Semiconductor Footprint
Positive
Feb 4, 2026

On January 27, 2026, ACM Research (Shanghai), Inc. held targeted investor meetings and an investor conference call, later summarized in a filing posted by the Shanghai Stock Exchange on January 29, 2026, to address questions about its recent performance and outlook. Management attributed a quarter‑over‑quarter revenue decline in the fourth quarter of 2025 primarily to delayed equipment deliveries and revenue recognition timing, and explained that differences in 2026 revenue guidance versus its U.S. parent stem from divergent accounting standards and revenue recognition rules. The company reaffirmed expectations for a 2026 gross margin of 42%–48% and R&D expenses at 14%–19% of revenue, highlighted strong and growing demand from both memory and logic customers, and emphasized continued investment in differentiated technologies and patent‑protected innovation to defend its competitive position amid ongoing market competition, particularly in cleaning equipment. ACM Shanghai detailed progress in expanding overseas sales, including deliveries to customers in Singapore and the United States and active expansion into Taiwan and South Korea, supported by an overseas manufacturing footprint in South Korea aimed at mitigating geopolitical and tariff risks. It also underscored advanced packaging and electroplating tools as key growth drivers—together contributing roughly 30% of estimated 2025 revenue—with advanced packaging expected to be a core revenue growth segment in 2026, alongside newly introduced platform-based products such as vertical furnace, Track, PECVD, LPCVD, and ALD systems and new panel-level packaging platforms targeted at the Taiwan market.

The most recent analyst rating on (ACMR) stock is a Buy with a $68.00 price target. To see the full list of analyst forecasts on ACM Research stock, see the ACMR Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
ACM Research Sets Price for ACM Shanghai Share Transfer
Neutral
Feb 3, 2026

On January 30, 2026, ACM Research (Shanghai), Inc. notified the Shanghai Stock Exchange that its parent, ACM Research, Inc., planned to sell 4,801,648 shares of ACM Shanghai through an inquiry-based share transfer. On February 2, 2026, ACM Shanghai announced that the preliminary transfer price was set at RMB 160.00 per share (approximately $23.05), based on quotations from 38 institutional investors, with valid subscriptions totaling about 5.64 million shares, or roughly 1.17 times the shares on offer, and 30 institutional investors preliminarily identified as transferees for the fully subscribed block. The company emphasized that the transfer remains subject to completion of registration with the China Securities Depository and Clearing Corporation’s Shanghai branch and potential risks such as judicial freezing or compulsory disposition, but noted that the transaction will not result in any change of control at ACM Shanghai or affect its corporate governance structure and ongoing operations.

The most recent analyst rating on (ACMR) stock is a Hold with a $64.00 price target. To see the full list of analyst forecasts on ACM Research stock, see the ACMR Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
ACM Research Plans Institutional Sale of ACM Shanghai Stake
Neutral
Jan 30, 2026

On January 30, 2026, ACM Research, Inc. notified the Shanghai Stock Exchange that it plans to sell 4,801,648 pre-IPO shares of its operating subsidiary ACM Research (Shanghai), Inc. through an inquiry-based transfer, representing about 1.34% of ACM Research’s stake in ACM Shanghai and roughly 1% of ACM Shanghai’s total shares outstanding as of that date. The sale, organized by Guotai Haitong Securities and limited to institutional investors, is driven by ACM Research’s capital needs and is structured outside centralized bidding or block trading, meaning it will not constitute a secondary-market share reduction, and proceeds are earmarked for general corporate purposes, signaling a modest equity monetization that leaves the parent’s controlling position in ACM Shanghai largely intact.

The most recent analyst rating on (ACMR) stock is a Hold with a $55.00 price target. To see the full list of analyst forecasts on ACM Research stock, see the ACMR Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 03, 2026